Latest Fredun Pharmaceuticals stock price
Fredun Pharmaceuticals P/E Ratio
FREDUN • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
32.99
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
32.99
Current Price
₹1479.05
EPS (TTM)
₹44.83
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
57.32
Sector Median
35.38
Sector Rank
#11 of 89
Sector Percentile
12.4%
Earnings Breakdown (TTM)
TTM EPS
₹76.11
Sept 2025
₹19.98
Mar 2025
₹12.71
Key P/E Ratio Insights for Fredun Pharmaceuticals
- Stock appears overvalued with PE of 32.99, suggesting caution for new investments
- Trading at discount to sector average PE of 57.32
View the FREDUN equity price for detailed stock performance.
Related Pages for Fredun Pharmaceuticals
Additional stock information and data for FREDUN
Sector P/E Ratio Comparison
Comparing Fredun Pharmaceuticals with other companies in Healthcare sector
Sector Average
57.32
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
89
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |